Type: Press Release
… multimedia View the full release here https//wwwbusinesswirecom/news/home/20190925005454/en/ Impella 55 with SmartAssist … the Impella control screen through a secure HIPAA compliant website to track and review cases at any time from any … literature reviews of 801 patients in 33 clinical studies Additionally more than 49000 patients supported by …
Type: Press Release
… highlights Total revenue for the quarter totaled $2526 million an increase of 53% compared to $1649 million during the same period of the … Prospective Payment System (IPPS) is available on the CMS website “Q1 was a solid start with record global revenue and …
Type: Press Release
… Februarys American Heart Month Throughout the month the company is sharing stories of patients with heart failure … the heart to rest and recover its native function we are committed to helping reduce the growing impact of heart … teams that made their Impella devices Christine Alber 26 suffered from symptoms that were thought to be bronchitis …
Type: Press Release
… unaudited total US revenue grew 8% to $1856 million from $1726 million in the prior fiscal year US patient usage grew 5% … with physicians Impella’s current clinical data FDA studies and best practices that support Impella’s indications … also be available on the investor section of the companys website at wwwabiomedcom A replay of the webcast will be …
Type: Press Release
… Percutaneous Coronary Intervention to improve patient outcomes and quality of life with supported high-risk PCI by … will be updated regularly on the password protected website with a rapidly expanding library for case-based …
Type: Press Release
… DANVERS Mass--(BUSINESS WIRE)--Oct 26 2020-- The United States Food and Drug Administration … Abiomed (NASDAQ ABMD) a 510(k) clearance for an all-in-one compact cardiopulmonary bypass system called the Abiomed … to unload the heart and oxygenate the body Multiple studies support the association of ECpella therapy to improve …
Type: Press Release
… best practices in contemporary PCI practice including more complete revascularization Participants received an …
Type: Press Release
… appropriate in patients with severe coronary artery disease complex anatomy and extensive comorbidities with or without … initial approval for High Risk PCI was based on two FDA studies (PROTECT I and PROTECT II) that treated the sickest and … Cardiovascular Care J Am Coll Cardiol 2015 May 1965(19)e7-e26 doi 101016/jjacc201503036 Epub 2015 Apr 7 ABOUT IMPELLA …
Type: Press Release
… second quarter fiscal 2014 revenue of $443 million up 19% compared to revenue of $374 million in the same period of … tax liability 6007 5554 Other long-term liabilities 262 309 Total liabilities 30315 32919 Commitments and … in capital 427183 414810 Accumulated deficit (258925) (258261) Treasury stock at cost - 1206367 shares at September 30 …
Type: Press Release
… fiscal 2019 revenue of $2006 million an increase of 30% compared to revenue of $1540 million for the same period of … and animations is available on the investor section of our website and at http//wwwabiomedcom/jpmorgan “We are proud of … net 138455 117167 Goodwill 33260 35808 In-process research and development …